| Molecular Modeling of the 3D Structure of 5-HT1AR: Discovery of Novel 5-HT1AR Agonists via Dynamic Pharmacophore-Based Virtual Screening L Xu, S Zhou, K Yu, B Gao, H Jiang, X Zhen, W Fu Journal of chemical information and modeling 53 (12), 3202-3211, 2013 | 33 | 2013 |
| Reforming China’s drug regulatory system L Xu, H Gao, KI Kaitin, L Shao Nat Rev Drug Discov 17 (12), 858-859, 2018 | 25 | 2018 |
| Regulatory watch: innovative drug availability in China L Shao, L Xu, Q Li, R Chakravarthy, Z Yang, KI Kaitin Nature Reviews Drug Discovery 15 (11), 739-741, 2016 | 25 | 2016 |
| Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold X Deng, L Guo, L Xu, X Zhen, K Yu, W Zhao, W Fu Bioorganic & Medicinal Chemistry Letters 25 (18), 3970-3974, 2015 | 17 | 2015 |
| Nursing home profit margins and citations for infection prevention and control H Sharma, L Xu Journal of the American Medical Directors Association 22 (11), 2378-2383. e2, 2021 | 12 | 2021 |
| Association between wages and nursing staff turnover in Iowa nursing homes H Sharma, L Xu Innovation in Aging 6 (4), igac004, 2022 | 11 | 2022 |
| Discovery of a novel 5-HT2A inhibitor by pharmacophore-based virtual screening ZJ Xiong, P Du, B Li, LL Xu, XC Zhen, W Fu Chem Res Chinese U 27 (4), 655-660, 2011 | 11 | 2011 |
| Dementia and cognitive decline in older adulthood: are agricultural workers at greater risk? K Arora, L Xu, D Bhagianadh The Journals of Gerontology: Series B 76 (8), 1629-1643, 2021 | 6 | 2021 |
| A computational perspective on drug discovery and signal transduction mechanism of dopamine and serotonin receptors in the treatment of schizophrenia P Lian, L Xu, C Geng, Y Qian, W Li, X Zhen, W Fu Current Pharmaceutical Biotechnology 15 (10), 916-926, 2014 | 6 | 2014 |
| Promoting quality of life and safety in assisted living: A survey of state monitoring and enforcement agents B Kaskie, L Xu, S Taylor, L Smith, P Cornell, W Zhang, P Carder, ... Medical Care Research and Review 79 (5), 731-737, 2022 | 5 | 2022 |
| Design, Synthesis, and Evaluation of Indolebutylamines as a Novel Class of Selective Dopamine D 3 Receptor Ligands P Du, L Xu, J Huang, K Yu, R Zhao, B Gao, H Jiang, W Zhao, X Zhen, ... Chemical Biology & Drug Design 82 (3), 326-335, 2013 | 5 | 2013 |
| Effect of medicaid expansion on health insurance for low-income nursing home aides L Xu, H Sharma Journal of applied gerontology 42 (2), 231-240, 2023 | 4 | 2023 |
| First year of skilled nursing facility value-based purchasing program penalizes facilities with poorer financial performance H Sharma, JG Hefele, L Xu, B Conkling Medical care 59 (12), 1099-1106, 2021 | 3 | 2021 |
| Patchwork protections: Regulatory oversight in assisted living L Smith, L Xu Public Policy & Aging Report 31 (2), 62-66, 2021 | 3 | 2021 |
| Impact of regulatory system changes on the availability of innovative drugs in China. Q Ge, L Xu, JA DiMasi, KI Kaitin, L Shao Nature reviews. Drug Discovery, 2023 | 2 | 2023 |
| Discovery of novel small-molecule Src kinase inhibitors via a kinase-focused druglikeness rule and structure-based virtual screening B Li, L Xu, Q Shen, X Gu, W Fu Molecular Simulation 40 (4), 341-348, 2014 | 2 | 2014 |
| Theoretical and NMR investigations on the conformations of (−)-meptazinol hydrochloride in solution W Li, L Xu, Q Xie, Y Chen, M Lu, B Chao, X Wang, Y Tang, Z Qiu, W Fu, ... Molecular Simulation 39 (13), 1065-1069, 2013 | 2 | 2013 |
| The effect of nursing home closure on local employment in the United States L Xu, H Sharma, GL Wehby Health services research 58 (3), 744-752, 2023 | 1 | 2023 |
| Profit status and employee turnover in Iowa nursing homes H Sharma, L Xu Innovation in aging 5 (Suppl 1), 568, 2021 | 1 | 2021 |
| Occupational Injuries in the US Nursing Homes H Sharma, L Xu Medical care 62 (5), 346-351, 2024 | | 2024 |
